The global thoracic catheters market size was valued at USD 424.20 million in 2025 and is projected to grow from USD 447.36 million in 2026 to USD 684.48 million by 2034, registering a CAGR of 5.46% during the forecast period (2026–2034). North America dominated the thoracic catheters market with a share of 41.30% in 2025.
Thoracic catheters are flexible medical tubes inserted into the chest or thoracic cavity to provide a passage for the drainage of air, blood, fluid, or other materials from the pleural or mediastinal space. These catheters are used in procedures involving conditions such as pneumothorax, pleural effusion, thoracic injury, and postoperative drainage. Thoracic catheters are tracked under HSN Code 9018 (instruments and appliances used in medical, surgical, dental, or veterinary sciences) and SIC Code 3841 (surgical and medical instruments and apparatus).
By Product Type
By Material
By Application
By End User
Download a Free Sample To learn more about this report,
Adoption of Small-Bore Thoracic Catheters
Expansion of Digital Thoracic Drainage Systems
Supply chain disruptions are expected to have a moderate impact on the thoracic catheters market share, as dependence on medical-grade polymers, catheter components, sterile packaging, and specialized manufacturing processes can create procurement delays and temporary product shortages. The market is likely to follow an elastic recovery pattern, as thoracic catheter procedures address urgent clinical needs and purchasing demand can return quickly once manufacturing, sterilization, and distribution constraints are resolved. The market is expected to grow at a CAGR of 5.46%, but supply chain constraints could approximately lower this by 0.5 percentage points, resulting in short-term growth of around 4.96%. As supply conditions normalize through steadier availability of medical-grade materials, restored manufacturing capacity, reliable sterilization operations, and improved medical-device distribution, thoracic catheters market growth is expected to gradually return to 5.46%.
The thoracic catheter market forecasts strategic investment activity driven by minimally invasive procedures, advanced catheter technologies, growing thoracic disease treatment needs, and demand for efficient chest drainage systems. In 2025, VQ Biomedical received USD 3.15 million in U.S. government funding, comprising a USD 750,000 BARDA contract under the Healing Lungs initiative and a USD 2.4 million DARPA SBIR agreement. The funding supports the development of minimally invasive intravascular oxygenation catheters for patients with acute respiratory distress syndrome (ARDS).
Pleural Effusion Burden and Focus on Postoperative Drainage Needs Drive Market Demand
Higher incidence of pleural effusion is increasing the need for pleural drainage to remove excess fluid from the chest cavity. Thoracic catheters support fluid removal in patients requiring pleural effusion management. A larger patient pool is therefore expanding demand for drainage catheters. Greater respiratory care requirements across hospitals further strengthen product demand.
The growing volumes of surgical procedures involving the chest are increasing the need for postoperative drainage of air and fluid from the thoracic cavity. Thoracic catheters help maintain proper drainage during the recovery period following surgery. Higher postoperative care requirements can therefore increase utilization of surgical catheters in hospitals. Greater emphasis on effective postoperative management can further support demand for chest drainage systems.
Postoperative Complications and Catheter Blockage Risks Restrain Market Expansion
Postoperative complications such as bleeding, infection, and tissue injury can occur after chest tube placement or prolonged use. These events can increase patient discomfort and extend recovery requirements in some cases. Additional clinical complications can also require further monitoring or intervention. Such risks limit the use of certain thoracic drainage devices.
Catheter blockage can occur when blood clots, tissue debris, or thick pleural fluid obstruct the drainage pathway. Reduced flow can affect the removal of air or fluid from the pleural space. Blockages can also interrupt consistent drainage during treatment, reducing the effectiveness of drainage catheters in complex cases.
Home-Based Thoracic Care and Expansion of Palliative Care Offer Growth Opportunities to Market Players
The expansion of home-based thoracic care is creating opportunities for thoracic catheters used in selected outpatient recovery and longer-term chest care. Portable catheter solutions can support continued patient management outside acute hospital settings. Wider adoption of respiratory care at home can broaden the market's care-setting reach.
The expansion of palliative care for patients with recurrent malignant pleural effusion offers growth opportunities for thoracic catheter manufacturers, pleural-device suppliers, palliative-care providers, and home-care service companies. Greater use of ambulatory and home-based symptom management creates demand for indwelling thoracic catheters that enable controlled drainage and relief of breathlessness while reducing the need for repeated hospital-based procedures.
Reimbursement Limitations and Variations in Physician Preferences Hinder Growth
Limited reimbursement coverage can reduce patient access to certain thoracic drainage procedures and related products. Differences in coverage policies may increase out-of-pocket expenses for patients and treatment facilities. These financial barriers can slow adoption across some healthcare settings.
Physician preference variation can influence the selection of chest tubes, drainage catheters, and other thoracic devices. Clinicians may favor familiar catheter designs, brands, or procedural approaches based on their experience. Such preferences can make market acceptance less consistent across hospitals.
The thoracostomy tubes segment accounted for a share of 54.8% in 2025, supported by the extensive use for draining air, fluid, and blood from the pleural space. Thoracostomy tubes are essential in managing pneumothorax, hemothorax, and postoperative drainage.
The pleural drainage catheters segment is expected to grow at a CAGR of 5.91% during the forecast period, driven by the demand for less invasive approaches to pleural drainage. Their smaller size and suitability for image-guided placement support adoption in selected pneumothorax treatment and pleural fluid drainage procedures.
Request Customizationto receive a tailored report.
The silicone segment accounted for a share of 43.7% in 2025, owing to the flexibility and biocompatibility of silicone for thoracic drainage applications. These properties support its use in chest tubes and long-term pleural drainage systems where patient comfort and reliable drainage are important.
The polyurethane segment is expected to grow at a CAGR of 6.02% during the forecast period, led by demand for flexible and small-bore catheter designs. Its suitability for minimally invasive pigtail and pleural drainage catheters supports adoption in procedures requiring smaller access routes.
The pneumothorax segment accounted for a share of 38.9% in 2025, supported by the established use of thoracic catheters to remove air from the pleural space and restore lung expansion. The clinical need for rapid pleural decompression in traumatic and spontaneous pneumothorax sustains demand for these devices.
The pleural effusion segment is expected to grow at a CAGR of 5.91% during the forecast period, propelled by the need for effective drainage of accumulated pleural fluid.
The hospitals segment accounted for a share of 68.4% in 2025, supported by the high volume of thoracic procedures performed in inpatient and emergency care settings.
The ambulatory surgical centers segment is expected to grow at a CAGR of 6.47% during the forecast period, led by the expansion of minimally invasive and outpatient thoracic procedures. Smaller catheter designs and image-guided placement support the use of thoracic drainage devices in settings requiring shorter procedures and reduced inpatient utilization.
Speak to an Analystto discuss market opportunities.
Market Dominance Led by Expansion of Critical Care
The North America thoracic catheter market accounted for the largest regional share of 41.30% in 2025, supported by advanced thoracic surgery, high demand for chest drainage systems and critical care devices, and established respiratory care facilities.
The U.S. thoracic catheter market size was valued at approximately USD 126.0 million in 2025. High volumes of thoracic trauma and emergency chest injuries are generating sustained demand for chest tubes and thoracic drainage devices in emergency departments and critical care units. The U.S. trauma care system also supports the use of thoracic catheters for hemothorax, tension pneumothorax, and chest injury management, creating a distinct demand base beyond routine postoperative drainage.
The Canada thoracic catheter market size was valued at approximately USD 18.5 million in 2025. Canada’s established cardiothoracic surgery and emergency-care infrastructure supports continued use of chest tubes and thoracic drainage systems for pneumothorax, pleural effusion, and postoperative drainage. Health Canada classifies thoracic drains (chest drains) as Class II medical devices, confirming their established role within the Canadian medical-device system.
Unlock Regional Insightsto access country-level data, & regional trends.
Fastest Growth Fueled by Aging Population and Healthcare Infrastructure Modernization
The Asia Pacific thoracic catheter market is expected to grow at a CAGR of 6.85% during the forecast period, supported by expanding thoracic surgery capacity, greater availability of specialized respiratory care, and wider adoption of minimally invasive pleural drainage procedures.
The Japan thoracic catheter market size was valued at approximately USD 22.0 million in 2025. Japan’s aging population, high prevalence of respiratory conditions, and advanced hospital-based pulmonary care are creating steady demand for thoracic catheters.
The China thoracic catheter market size was valued at approximately USD 54.0 million in 2025. A large hospital network, expanding critical-care capacity, and greater access to interventional pulmonology are broadening the use of thoracic catheters.
The India thoracic catheter market size was valued at approximately USD 28.0 million in 2025. Greater availability of emergency medicine and trauma care is creating more opportunities for thoracic drainage devices. The Ayushman Bharat health infrastructure program has supported expansion and upgrading of public health facilities, strengthening the treatment infrastructure for thoracic conditions.
Market Growth by Preference for Minimally Invasive Treatment Approaches
The Europe thoracic catheter market is expected to grow at a CAGR of 5.18% during the forecast period, supported by expanding ambulatory surgical care, increasing management of traumatic chest conditions, and broader adoption of minimally invasive thoracic procedures.
The UK thoracic catheter market size was valued at USD 22.0 million in 2025. NHS England recognizes adult thoracic surgery as a specialized service, while major NHS centers increasingly use minimally invasive approaches such as VATS and robotic surgery.
The Germany thoracic catheter market size was valued at USD 27.0 million in 2025. A high burden of trauma-related chest injuries and demand for rapid pleural decompression are supporting use of thoracic catheters in emergency and surgical care.
Market Expansion Led by Focus on Specialized Pleural Care
The Latin America thoracic catheter market is expected to grow at a CAGR of 5.76% during the forecast period, supported by improving access to specialized pulmonary care, increasing use of pleural interventions, and expansion of diagnostic capabilities. Brazil’s established respiratory and thoracic-care network is supporting the use of chest tubes and drainage catheters for pleural effusions and pneumothorax. Mexico’s expanding interventional pulmonology services are creating additional opportunities for minimally invasive thoracic drainage.
Market Growth Led by Healthcare Digitization
The Middle East & Africa thoracic catheter market is expected to grow at a CAGR of 5.92% during the forecast period, supported by healthcare digitization and broader adoption of technology-enabled thoracic procedures. Dubai Health Authority’s 2025 digital health initiatives are strengthening digital clinical workflows and real-time data access in the UAE. The South Africa thoracic catheter market benefits from the expansion of intensive care and emergency medicine services, where chest drainage devices are required for acute thoracic conditions.
The thoracic catheters market competitive landscape is moderately concentrated, with participation from global medical device manufacturers, catheter specialists, respiratory care companies, hospital supply providers, and regional product manufacturers. Leading players such as Teleflex Incorporated, Getinge AB, BD, Cardinal Health, Inc., and Poly Medicure Limited are collectively estimated to account for approximately 35–40% of the global thoracic catheters market share.
Established participants compete primarily through catheter design, drainage performance, and patient safety. Emerging, niche, and regional companies in the thoracic catheters market ecosystem compete through application-specific catheter designs, minimally invasive configurations, and cost-effective products.
February 2026: ClearFlow received an Innovative Technology contract from Vizient for its PleuraFlow Active Clearance Technology (ACT).
February 2026: Medela's Thopaz+ Digital Chest Drainage System was awarded a contract by Vizient.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Home Healthcare Devices Market Size, Share, Growth, Analysis, Report, 2034
Europe Diabetes Devices Market Size & Trends by 2034
Asia Pacific Diabetes Devices Market Size & Trends by 2034
Middle East and Africa Medical Screws and Plates Market Size, Growth by 2034
Medical Digital Imaging System Market Size, Share, Growth, 2034
Latin America Diabetes Devices Market Size & Trends by 2034
We are featured on:
sales@straitsresearch.com